Clinical Trials Directory

Trials / Completed

CompletedNCT03862794

CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9

A Randomized Controlled Trial of Behaviourally Informed Feedback Letters Sent by the Chief Medical Officer on the Amount of Antibiotics and the Percentage of Broad Spectrum Antibiotics Prescribed in Primary Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7,000 (actual)
Sponsor
Public Health England · Other Government
Sex
All
Age
Healthy volunteers
Accepted

Summary

This trial aims to reduce unnecessary prescription of antibiotics and broad spectrum antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically the sample was GPs whose practices whose prescribed more than 1.161 items per STAR-PU or whose practices prescribed more that .965 items per STAR-PU and greater than 10% broad spectrum items. The intervention groups received a letter telling them they are among the highest prescribers of either their total or broad spectrum antibiotics, with a graph showing their prescribing compared to average prescribing ("their peers"). The letter also contained a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.

Conditions

Interventions

TypeNameDescription
BEHAVIORALnew social norm feedback letter with bar chartletter with the percentile prescribing the practice is on and a bar chart, comparing prescribing to the national average
BEHAVIORALstandard social norm feedback lettersocial norm feedback letter used as standard practice, without specific information about the prescribing percentile

Timeline

Start date
2018-11-01
Primary completion
2019-04-30
Completion
2019-05-30
First posted
2019-03-05
Last updated
2020-03-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03862794. Inclusion in this directory is not an endorsement.